Immunological and metabolic effects of prophylactic insulin therapy in the NOD-scid/scid adoptive transfer model of IDDM

Diabetes

Volumn 45, Issue 2, 1996, Pages 205-208

  Bowman, Mark A ^a   Campbell, Lalita ^a   Darrow, Bethany L ^a   Ellis, Tamir M ^a   Suresh, Alaparthy ^a   Atkinson, Mark A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; DRUG VEHICLE; HUMULIN U; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; OCTREOTIDE; SOMATOSTATIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INSULITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPLEEN CELL;

EID: 0030050676     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.2.205     Document Type: Article

References (18)

1. Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428-1436, 1994
2. Godfredsen CF, Buschard K, Frandsen EK: Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetolagia 28:933-935, 1985
3. Like AA: Insulin injections prevent diabetes in BioBreeding/Worcester rats. Diabetes 35 (Suppl. 1):74A, 1986
4. Atkinson MA, Maclaren NK, Luchetta R: Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933-937, 1990
5. Thivolet CH, Goillot E, Bedossa P, Durand A, Bonnard M, Orgiazzi J: Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetologia 34:314-319, 1991
6. Keller RJ, Eisenbarth GS, Jackson RA: Insulin prophylaxis in individuals at high risk of type 1 diabetes. Lancet 341:927-928, 1993
7. Bock T, Pedersen CR, Josefsen K, Bottazzo GF, Palmer JP, Buschard K. No risk of diabetes after insulin-shock treatment. Lancet 339:1504-1506, 1992
8. Zhang JZ, Davidson L, Eisenbarth GS, Weiner HL: Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 88.10252-10256, 1991
9. Muir A, Peck A, Clare-Salzler M, Song YH, Cornelius J, Luchetta R, Krischer J, Maclaren N: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J Clin Invest 95:628-634, 1995
10. Shah SC, Malone JI, Simpson NE. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus N Engl J Med 320:550-554, 1989
11. Buschard K. The functional state of the beta cells in the pathogenesis of insulin dependent diabetes mellitus. Autoimmunity 10:65-69, 1991
12. a donors. Diabetes 42:44-55, 1993
13. Brogden RN, Heel RC Human insulin: a review of its biological activity pharmacokinetics and therapeutic use. Drugs 34:1350-371, 1987
14. Haist RE, Campbell J, Best CH. The prevention of insulin dependent diabetes. N Engl J Med 223:607-615, 1940
15. Vlahos WD, Seemayer TA, Yale JF. Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. Metabolism 40:825-829, 1991
16. Williams AJ, Beales PE, Krug J, Procaccini E, Signore A, Xu S, Gale EA, Pozzilli P: Tolbutamide reduces the incidence of diabetes mellitus but not insulitis in the non-obese-diabetic mouse. Diabetologia 36:487-492, 1993
17. Bock T, Kjaer TW, Jorgensen M, Josefsen K, Rygaard J, Buschard K: Reduction of diabetes incidence in NOD mice by neonatal glucose treatment. APMIS 99:989-992, 1991
18. Schloot N, Eisenbarth GS: Isohormonal therapy of endocrine autoimmunity. Immunol Today 16:289-294, 1995